Cargando…
A Health Economic Analysis for Oral Poliovirus Vaccine to Prevent COVID‐19 in the United States
COVID‐19 led to a recent high‐profile proposal to reintroduce oral poliovirus vaccine (OPV) in the United States (U.S.), initially in clinical trials, but potentially for widespread and repeated use. We explore logistical challenges related to U.S. OPV administration in 2020, review the literature r...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7983986/ https://www.ncbi.nlm.nih.gov/pubmed/33084153 http://dx.doi.org/10.1111/risa.13614 |